NeurAxis, Inc.

Healthcare

AMEX:NRXS · New York Stock Exchange American

Market Cap $88.55M Beta 1.41 P/E (TTM) -10.5
$7.15 +4.25%

+$0.29 today

52W Low $2.20High $9.33

Vol 0.13M · Avg 0.18M

EPS (TTM) -$0.67Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+201.69%

Period High

$8.81

Period Low

$2.31

Latest

$7.15

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
Rallybio Corporation

Rallybio Corporation

NASDAQ:RLYB

$92.36M

NE

Minerva Neurosciences, Inc.

NERV

$29.51M

KL

Klotho Neurosciences, Inc.

KLTO

$20.08M

NR

NeuroSense Therapeutics Ltd.

NRSN

$18.50M

XC

Exicure, Inc.

XCUR

$15.52M

EN

Enlivex Therapeutics Ltd.

ENLV

$15.06M

TA

TAO Synergies Inc.

TAOX

$12.15M

CV

Cadrenal Therapeutics, Inc. Common Stock

CVKD

$9.35M

SO

Sonnet BioTherapeutics Holdings, Inc.

SONN

$8.43M

CL

CollPlant Biotechnologies Ltd.

CLGN

$4.03M

What is the latest NRXS filing?

The latest filing shown is 8-K dated Jun 12, 2026.

How many recent filings does NRXS have?

Intrinsic Alpha currently shows 20 recent filings for NRXS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.